Advanced Lymphoma Clinical Trials

5 recruiting

Advanced Lymphoma Trials at a Glance

7 actively recruiting trials for advanced lymphoma are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 1 with 5 trials, with the heaviest enrollment activity in Nagpur, Pune, and Bhubaneswar. Lead sponsors running advanced lymphoma studies include Aurigene Discovery Technologies Limited, Adlai Nortye Biopharma Co., Ltd., and CStone Pharmaceuticals.

Browse advanced lymphoma trials by phase

Treatments under study

About Advanced Lymphoma Clinical Trials

Looking for clinical trials for Advanced Lymphoma? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Advanced Lymphoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Advanced Lymphoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Advanced Colorectal CarcinomaAdvanced Anal CarcinomaAdvanced Biliary Tract Carcinoma+41 more
Mayo Clinic220 enrolled2 locationsNCT05969860
Recruiting
Phase 1

A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)

Relapsed Advanced Lymphomas
Aurigene Discovery Technologies Limited40 enrolled27 locationsNCT05984147
Recruiting
Phase 1

Studying TAK-243 in Patients With Advanced Cancer

Advanced Malignant Solid NeoplasmAdvanced Lymphoma
National Cancer Institute (NCI)95 enrolled1 locationNCT06223542
Recruiting
Phase 1

Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma

Relapsed Advanced Lymphomas
Aurigene Discovery Technologies Limited40 enrolled19 locationsNCT06755450
Recruiting
Phase 1

First in Human, Dose Escalation Study of AN4005

Advanced Solid TumorAdvanced Lymphoma
Adlai Nortye Biopharma Co., Ltd.31 enrolled7 locationsNCT04999384
Recruiting
Phase 1

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

Advanced Solid TumorAdvanced Lymphoma
CStone Pharmaceuticals480 enrolled38 locationsNCT05279300
Recruiting

Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies

Advanced LymphomaRefractory Acute Myeloid LeukemiaRefractory Lymphoma+2 more
Medical University of Vienna150 enrolled1 locationNCT04470947